MARKET

DTCFF

DTCFF

Defence Therapeu
OTCMQB
0.463
0.000
0.09%
Closed 14:41 03/05 EST
OPEN
0.463
PREV CLOSE
0.462
HIGH
0.463
LOW
0.463
VOLUME
2.50K
TURNOVER
1.16K
52 WEEK HIGH
0.996
52 WEEK LOW
0.386
MARKET CAP
26.52M
P/E (TTM)
-7.8523
1D
5D
1M
3M
1Y
5Y
1D
Defence Therapeutics Targets Global Partnerships as It Showcases Accum Platform at March Industry Events
TipRanks · 3d ago
Weekly Report: what happened at DTCFF last week (0223-0227)?
Weekly Report · 3d ago
Defence Therapeutics to Attend BIO-Europe Spring in Lisbon
Reuters · 3d ago
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
Newsfile · 3d ago
Defence Therapeutics Seeks Up to $11 Million in Structured Private Placement
TipRanks · 6d ago
Defence Therapeutics to raise up to $11 million in private placement
Seeking Alpha · 6d ago
Defence Therapeutics launches up to $11 million private placement of units
Reuters · 6d ago
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
Newsfile · 6d ago
More
About DTCFF
Defence Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is engaged in developing and engineering the antibody drug conjugates (ADC) products using its proprietary platform. Its principal business activity is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological-/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The core of its therapeutics platform is the ACCUM technology, which enables precision delivery ADCs in their intact form to target cells. The Company is focused on research, development and advancement of the main products using its Accum technology, which include ADC targeting various cancers, Anti-cancer AccuTOX program, Mesenchymal stromal cell-based vaccine (ARM-X) targeting cancer, mRNA vaccination, Cervical cancer vaccine, and Radio-immunoconjugates (RIC) targeting various cancers.

Webull offers Defence Therapeutics Inc stock information, including OTCMQB: DTCFF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DTCFF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DTCFF stock methods without spending real money on the virtual paper trading platform.